KPTI
Price
$3.77
Change
-$0.08 (-2.07%)
Updated
Apr 4, 04:58 PM (EDT)
Capitalization
32.99M
27 days until earnings call
NTLA
Price
$6.63
Change
-$0.26 (-3.77%)
Updated
Apr 4, 04:58 PM (EDT)
Capitalization
712.2M
27 days until earnings call
Ad is loading...

KPTI vs NTLA

Header iconKPTI vs NTLA Comparison
Open Charts KPTI vs NTLABanner chart's image
Karyopharm Therapeutics
Price$3.77
Change-$0.08 (-2.07%)
Volume$2.85K
Capitalization32.99M
Intellia Therapeutics
Price$6.63
Change-$0.26 (-3.77%)
Volume$43.5K
Capitalization712.2M
KPTI vs NTLA Comparison Chart
Loading...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPTI vs. NTLA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPTI is a Hold and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (KPTI: $3.86 vs. NTLA: $6.89)
Brand notoriety: KPTI and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPTI: 311% vs. NTLA: 114%
Market capitalization -- KPTI: $32.99M vs. NTLA: $712.2M
KPTI [@Biotechnology] is valued at $32.99M. NTLA’s [@Biotechnology] market capitalization is $712.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPTI’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • KPTI’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both KPTI and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPTI’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • KPTI’s TA Score: 4 bullish, 4 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KPTI is a better buy in the short-term than NTLA.

Price Growth

KPTI (@Biotechnology) experienced а -11.26% price change this week, while NTLA (@Biotechnology) price change was -17.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.64%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

KPTI is expected to report earnings on May 01, 2025.

NTLA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($712M) has a higher market cap than KPTI($33M). NTLA YTD gains are higher at: -40.909 vs. KPTI (-61.950). KPTI has higher annual earnings (EBITDA): -38.6M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. KPTI (109M). KPTI has less debt than NTLA: KPTI (195M) vs NTLA (210M). KPTI has higher revenues than NTLA: KPTI (145M) vs NTLA (57.9M).
KPTINTLAKPTI / NTLA
Capitalization33M712M5%
EBITDA-38.6M-523.98M7%
Gain YTD-61.950-40.909151%
P/E RatioN/AN/A-
Revenue145M57.9M250%
Total Cash109M602M18%
Total Debt195M210M93%
FUNDAMENTALS RATINGS
KPTI vs NTLA: Fundamental Ratings
KPTI
NTLA
OUTLOOK RATING
1..100
5464
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9794
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (4) in the Biotechnology industry is in the same range as NTLA (25). This means that KPTI’s stock grew similarly to NTLA’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NTLA (100). This means that KPTI’s stock grew similarly to NTLA’s over the last 12 months.

NTLA's SMR Rating (97) in the Biotechnology industry is in the same range as KPTI (100). This means that NTLA’s stock grew similarly to KPTI’s over the last 12 months.

NTLA's Price Growth Rating (94) in the Biotechnology industry is in the same range as KPTI (97). This means that NTLA’s stock grew similarly to KPTI’s over the last 12 months.

NTLA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as KPTI (100). This means that NTLA’s stock grew similarly to KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPTINTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAK15.190.21
+1.40%
Takeda Pharmaceutical Company Limited
WYY3.13-0.12
-3.69%
WidePoint Corp
NRP99.50-5.11
-4.88%
Natural Resource Partners LP
SPIR7.61-0.49
-6.05%
Spire Global
PTEN6.93-1.63
-19.04%
Patterson-UTI Energy